Form D · Investing
LWM Concentrated Biotech Fund, LLC
Glen Ellyn, IL · CIK 0001821414
Offering snapshot reported Feb 23, 2022 · SEC filing
- Reported sold
- $6.55M Indefinite offering
- Investors reported
- 60 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Sep 1, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,773,865 → $6,548,254
- Reported investors41 → 60
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2022 | Amendment | $6,548,254 | $1,774,389vs Sep 4, 2020 | 60 | SEC filing |
| Sep 4, 2020 | Initial | $4,773,865 | No comparison | 41 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-374930
Source: Form D, filed Feb 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy Boynton | Director |
Issuer details
Industry: Investing (See others in industry)
Address:
460 North Main Street, Ste 304
Glen Ellyn, IL, 60137
Glen Ellyn, IL, 60137